The management of pulmonary hypertension has already incorporated the use of multiple therapies into routine practice. Available therapies act principally through vasodilatation of the pulmonary ...
Future Cardiol. 2013;9(3):335-349. The efficacy of ambrisentan was demonstrated in the concurrent ARIES-1 and -2 trials. [80] ARIES-1 randomized 202 patients with PAH to either placebo or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback